Chronic Kidney Disease Trial, Recruiting NCT06364358 Sponsor: University of Chicago Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06364358
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as African American
  • Adults between the ages of 18 and 70
  • People whose kidneys are working at a reduced level, specifically with a kidney function score (called eGFR) below 45, due to a long-term kidney condition
  • People who are already enrolled in a program called the Hospitalist Project as a hospital inpatient

Who may not be able to join:

  • People who do not self-identify as African American
  • People who are not able to give their own consent to participate
  • People who are not able to speak English
  • People whose reduced kidney function score (eGFR below 45) is caused by a sudden, short-term kidney injury rather than a long-term condition
  • People who are currently being treated in an Intensive Care Unit (ICU)
  • People who have previously had an organ transplant
  • People who are currently receiving dialysis (a treatment that does the work of the kidneys)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Milda Saunders, MD, Associate Professor of Medicine

Phone: 7737025941

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 May 2023
Est. completion
1 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in CKD Knowledge baseline to post patient education intervention; Change in Knowledge about end stage kidney disease (ESKD) treatments from baseline to 1 day post patient education intervention; Change in ESKD Treatment Preferences from baseline to 1 day post-intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov